EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High risk of lung cancer in surfactant-related gene variant carriers

Alexandre Brudon iD, Marie Legendre iD, Arthur Mageau, Julien Bermudez, Philippe Bonniaud, Diane Bouvry, Jacques Cadranel, Aurélie Cazes, Bruno Crestani iD, Tristan Dégot, Céline Delestrain, Rémi Diesler iD und 34 weitere

European Respiratory Journal · 2024

DOI: 10.1183/13993003.01809-2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Alexandre Brudon und 45 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Oncologie Thoracique, Hôpital Bichat, AP-HP, Institut du Cancer AP-HP Nord, Paris, France. Hauptthemen laut MEDLINE: Lung Neoplasms, Pulmonary Surfactant-Associated Protein C, Pulmonary Surfactant-Associated Protein A. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several rare surfactant-related gene (SRG) variants associated with interstitial lung disease are suspected to be associated with lung cancer, but data are missing. We aimed to study the epidemiology and phenotype of lung cancer in an international cohort of SRG variant carriers.

Methods

We conducted a cross-sectional study of all adults with SRG variants in the OrphaLung network and compared lung cancer risk with telomere-related gene (TRG) variant carriers.

Results

We identified 99 SRG adult variant carriers ( SFTPA1 (n=18), SFTPA2 (n=31), SFTPC (n=24), ABCA3 (n=14) and NKX2-1 (n=12)), including 20 (20.2%) with lung cancer ( SFTPA1 (n=7), SFTPA2 (n=8), SFTPC (n=3), NKX2-1 (n=2) and ABCA3 (n=0)). Among SRG variant carriers, the odds of lung cancer was associated with age (OR 1.04, 95% CI 1.01–1.08), smoking (OR 20.7, 95% CI 6.60–76.2) and SFTPA1 / SFTPA2 variants (OR 3.97, 95% CI 1.39–13.2). Adenocarcinoma was the only histological type reported, with programmed death ligand-1 expression ≥1% in tumour cells in three samples. Cancer staging was localised (I/II) in eight (40%) individuals, locally advanced (III) in two (10%) and metastatic (IV) in 10 (50%). We found no somatic variant eligible for targeted therapy. Seven cancers were surgically removed, 10 received systemic therapy, and three received the best supportive care according to their stage and performance status. The median overall survival was 24 months, with stage I/II cancers showing better survival. We identified 233 TRG variant carriers. The comparative risk (subdistribution hazard ratio) for lung cancer in SRG patients versus TRG patients was 18.1 (95% CI 7.1–44.7).

Conclusions

The high risk of lung cancer among SRG variant carriers suggests specific screening and diagnostic and therapeutic challenges. The benefit of regular computed tomography scan follow-up should be evaluated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPulmonary Surfactant-Associated Protein CPulmonary Surfactant-Associated Protein AHumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesAdultThyroid Nuclear Factor 1ATP-Binding Cassette TransportersRisk FactorsGenetic Predisposition to DiseaseLung Diseases, InterstitialHeterozygotePulmonary Surfactant-Associated Proteins

Substanzen

ABCA3 protein, humanPulmonary Surfactant-Associated Protein CPulmonary Surfactant-Associated Protein ASFTPC protein, humanSFTPA1 protein, humanNKX2-1 protein, humanThyroid Nuclear Factor 1SFTPA2 protein, humanATP-Binding Cassette TransportersPulmonary Surfactant-Associated Proteins

Autor:innen und Institutionen

  • Service d'Oncologie Thoracique, Hôpital Bichat, AP-HP, Institut du Cancer AP-HP Nord, Paris, France.
  • Université Paris Cité, Inserm CIC-EC 1425, Paris, France.
  • A. Brudon and M. Legendre contributed equally to this work.
  • UF de Génétique Moléculaire, Hôpital Armand Trousseau, AP-HP, Paris, France.
  • Sorbonne Université, Inserm UMR-S 933, Maladies Génétiques d'Expression Pédiatrique, Paris, France.
  • Département de Médecine Interne, Hôpital Bichat, AP-HP, Paris, France.

ORCID-Profile: Alexandre Brudon, Marie Legendre, Bruno Crestani, Rémi Diesler, Ralph Epaud, Caroline Kannengiesser, Marie-Pierre Debray, Pascale Fanen, Nadia Nathan, Anne Guillaumot, Stephane Jouneau, Guillaume Beltramo, Yurdagul Uzunhan, Sylvain Marchand-Adam, Vincent Cottin, Raphael Borie

Zitieren

APA

Brudon, A., Legendre, M., Mageau, A., Bermudez, J., Bonniaud, P., Bouvry, D., Cadranel, J., Cazes, A., Crestani, B., Dégot, T., Delestrain, C., Diesler, R., Epaud, R., Philippot, Q., Théou-Anton, N., Kannengiesser, C., Ba, I., Debray, M. P., Fanen, P., …, & OrphaLung network (2024). High risk of lung cancer in surfactant-related gene variant carriers. European Respiratory Journal. https://doi.org/10.1183/13993003.01809-2023

Vancouver

Brudon A, Legendre M, Mageau A, Bermudez J, Bonniaud P, Bouvry D, et al. High risk of lung cancer in surfactant-related gene variant carriers. European Respiratory Journal. 2024. doi:10.1183/13993003.01809-2023

BibTeX
@article{Brudon2024,
  author = {Brudon, Alexandre and Legendre, Marie and Mageau, Arthur and Bermudez, Julien and Bonniaud, Philippe and Bouvry, Diane and Cadranel, Jacques and Cazes, Aurélie and Crestani, Bruno and Dégot, Tristan and Delestrain, Céline and Diesler, Rémi and Epaud, Ralph and Philippot, Quentin and Théou-Anton, Nathalie and Kannengiesser, Caroline and Ba, Ibrahima and Debray, Marie-Pierre and Fanen, Pascale and Manali, Efrosine and Papiris, Spyros and Nathan, Nadia and Amselem, Serge and Gondouin, Antoine and Guillaumot, Anne and Andréjak, Claire and Jouneau, Stephane and Beltramo, Guillaume and Uzunhan, Yurdagul and Galodé, François and Westeel, Virginie and Mehdaoui, Anas and Hirschi, Sandrine and Leroy, Sylvie and Marchand-Adam, Sylvain and Nunes, Hilario and Picard, Clément and Prévot, Grégoire and Reynaud-Gaubert, Martine and De Vuyst, Paul and Wemeau, Lidwine and Defossez, Gautier and Zalcman, Gérard and Cottin, Vincent and Borie, Raphael and OrphaLung network, OrphaLung network},
  title = {High risk of lung cancer in surfactant-related gene variant carriers},
  journal = {European Respiratory Journal},
  year = {2024},
  doi = {10.1183/13993003.01809-2023}
}
Kostenlos starten →